column
Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer
Yifan Feng, Chengjuan Chen, Anqi Shao, Lei Wu, Haiyu Hu, Tiantai Zhang,
2024, 14(12):5091-5105. DOI:10.1016/j.apsb.2024.09.008
Abstract
Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer
Danrong Hu, Yicong Li, Ran Li, Meng Wang, Kai Zhou, Chengqi He, Quan Wei, Zhiyong Qian,
2024, 14(12):5106-5131. DOI:10.1016/j.apsb.2024.10.015
Abstract
Respiratory delivered vaccines: Current status and perspectives in rational formulation design
Lan Wu, Wenwen Xu, Huiyang Jiang, Mingshi Yang, Dongmei Cun,
2024, 14(12):5132-5160. DOI:10.1016/j.apsb.2024.08.026
Abstract
Microneedles as transdermal drug delivery system for enhancing skin disease treatment
Chaoxiong Wu, Qingyu Yu, Chenlu Huang, Fangzhou Li, Linhua Zhang, Dunwan Zhu,
2024, 14(12):5161-5180. DOI:10.1016/j.apsb.2024.08.013
Abstract
Reductive stress—a common metabolic feature of obesity and cancer
Man Luo, Xiwen Ma, Jianping Ye,
2024, 14(12):5181-5185. DOI:10.1016/j.apsb.2024.08.034
Abstract
Comparison of Jinzhen oral liquid and ambroxol hydrochloride and clenbuterol hydrochloride oral solution in the treatment of acute bronchitis in children: A multicenter, non-inferiority, prospective, randomized controlled trial
Qinhua Fan, Chongming Wu, Yawei Du, Boyang Wang, Yanming Xie, Zeling Zhang, Wenquan Su, Zizhuo Wang, Changchang Xu, Xueke Li, Ying Ding, Xinjiang An, Jing Chen, Yunying Xiao, Rong Yu, Nan Li, Juan Wang, Yiqun Teng, Hongfen Lv, Nian Yang, Yuling Wen, Xiaoli Huang, Wei Pan, Yufeng Liu, Xueqin Xi, Qianye Zhao, Changshan Liu, Jian Xu, Haitao Zhang, Lie Zhuo, Qiangquan Rong, Yu Xia, Qin Shen, Shao Li, Junhong Wang, Shengxian Wu,
2024, 14(12):5186-5200. DOI:10.1016/j.apsb.2024.09.001
Abstract
UBE2G2 inhibits vasculogenic mimicry and metastasis of uveal melanoma by promoting ubiquitination of LGALS3BP
Andi Zhao, Chenyu Zhou, Jinjing Li, Zijin Wang, Hui Zhu, Shiya Shen, Qing Shao, Qi Gong, Hu Liu, Xuejuan Chen,
2024, 14(12):5201-5218. DOI:10.1016/j.apsb.2024.09.005
Abstract
DNMT3A loss drives a HIF-1-dependent synthetic lethality to HDAC6 inhibition in non-small cell lung cancer
Jiayu Zhang, Yingxi Zhao, Ruijuan Liang, Xue Zhou, Zhonghua Wang, Cheng Yang, Lingyue Gao, Yonghao Zheng, Hui Shao, Yang Su, Wei Cui, Lina Jia, Jingyu Yang, Chunfu Wu, Lihui Wang,
2024, 14(12):5219-5234. DOI:10.1016/j.apsb.2024.08.025
Abstract
Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells
Yingying Wang, Youping Zhang, Hao Luo, Wei Wei, Wanting Liu, Weiwei Wang, Yunzhao Wu, Cheng Peng, Yanjie Ji, Jianfang Zhang, Chujiao Zhu, Wenhui Bai, Li Xia, Hu Lei, Hanzhang Xu, Leimiao Yin, Wei Weng, Li Yang, Ligen Liu, Aiwu Zhou, Yueyue Wei, Qi Zhu, Weiliang Zhu, Yongqing Yang, Zhijian Xu, Yingli Wu,
2024, 14(12):5235-5248. DOI:10.1016/j.apsb.2024.08.019
Abstract
Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
Huizhu Liu, Xuejing Lv, Xin Zhao, Lanxing Yi, Ning Lv, Wendong Xu, Yuqiu Zhang,
2024, 14(12):5249-5266. DOI:10.1016/j.apsb.2024.09.016
Abstract
Intestinal epithelial cell NCoR deficiency ameliorates obesity and metabolic syndrome
Shaocong Hou, Hengcai Yu, Caihong Liu, Andrew M. F. Johnson, Xingfeng Liu, Qian Jiang, Qijin Zhao, Lijuan Kong, Yanjun Wan, Xiaowei Xing, Yibing Chen, Jingwen Chen, Qing Wu, Peng Zhang, Changtao Jiang, Bing Cui, Pingping Li,
2024, 14(12):5267-5285. DOI:10.1016/j.apsb.2024.09.019
Abstract
Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol
Ruiyang Gao, Bei Yue, Cheng Lv, Xiaolong Geng, Zhilun Yu, Hao Wang, Beibei Zhang, Fangbin Ai, Ziyi Wang, Donghui Liu, Zhengtao Wang, Kaixian Chen, Wei Dou,
2024, 14(12):5286-5304. DOI:10.1016/j.apsb.2024.09.018
Abstract
AKR1C1 interacts with STAT3 to increase intracellular glutathione and confers resistance to oxaliplatin in colorectal cancer
Zhiwen Fu, Tingting Wu, Chen Gao, Lulu Wang, Yu Zhang, Chen Shi,
2024, 14(12):5305-5320. DOI:10.1016/j.apsb.2024.08.031
Abstract
Avenanthramide A potentiates Bim-mediated antineoplastic properties of 5-fluorouracil via targeting KDM4C/MIR17HG/GSK-3β negative feedback loop in colorectal cancer
Rong Fu, Zhangfeng Dou, Ning Li, Xueyuan Fan, Sajid Amin, Jinqi Zhang, Yuqing Wang, Zongwei Li, Zhuoyu Li, Peng Yang,
2024, 14(12):5321-5340. DOI:10.1016/j.apsb.2024.07.018
Abstract
Thio-ProTide strategy: A novel H2S donor-drug conjugate (DDC) alleviates hepatic injury via innate lysosomal targeting
Haowen Jin, Jie Ma, Bixin Xu, Sitao Xu, Tianyu Hu, Xin Jin, Jiankun Wang, Guangji Wang, Le Zhen,
2024, 14(12):5341-5356. DOI:10.1016/j.apsb.2024.10.017
Abstract
Discovery of highly potent phosphodiesterase-1 inhibitors by a combined-structure free energy perturbation approach
Zhe Li, Mei-Yan Jiang, Runduo Liu, Quan Wang, Qian Zhou, Yi-You Huang, Yinuo Wu, Chang-Guo Zhan, Hai-Bin Luo,
2024, 14(12):5357-5369. DOI:10.1016/j.apsb.2024.06.021
Abstract
Pretheranostic agents with extraordinary NIRF/photoacoustic imaging performance and photothermal oncotherapy efficacy
Liu Shi, Zhenzhou Chen, Jiaxin Ou, En Liang, Zhipeng Chen, Qiuyue Fu, Lan Huang, Kui Cheng,
2024, 14(12):5370-5381. DOI:10.1016/j.apsb.2024.07.017
Abstract
Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy
Lu Liu, Yuanlai Qiu, Yuying Suo, Siyao Tong, Yiqing Wang, Xi Zhang, Liang Chen, Yue Huang, Huchen Zhou, Hu Zhou, Ze Dong, Cai-Guang Yang,
2024, 14(12):5382-5392. DOI:10.1016/j.apsb.2024.07.016
Abstract
A microfluidic coculture model for mapping signaling perturbations and precise drug screening against macrophage-mediated dynamic myocardial injury
Zhao Gao, Zhiyong Du, Yu Hou, Kun Hua, Pengfei Tu, Xiaoni Ai, Yong Jiang,
2024, 14(12):5393-5406. DOI:10.1016/j.apsb.2024.11.004
Abstract
A morphologically transformable hypoxia-induced radical anion for tumor-specific photothermal therapy
Hongyu Wang, Dengyuan Hao, Qihang Wu, Tingting Sun, Zhigang Xie,
2024, 14(12):5407-5417. DOI:10.1016/j.apsb.2024.09.017
Abstract
Development of a bacteria-nanosapper for the active delivery of ZIF-8 particles containing therapeutic genes for cancer immune therapy
Yiting Qiao, Miao Luo, Yufei Wang, Haoxiang Qi, Menglan Wang, Yunxin Pei, Mengqing Sun, Zhengguo Zhang, Jiacheng Huang, Pengyu Gong, Shusen Zheng, Jianxiang Chen,
2024, 14(12):5418-5434. DOI:10.1016/j.apsb.2024.07.020
Abstract
Nanoengineered mitochondria enable ocular mitochondrial disease therapy via the replacement of dysfunctional mitochondria
Yi Wang, Nahui Liu, Lifan Hu, Jingsong Yang, Mengmeng Han, Tianjiao Zhou, Lei Xing, Hulin Jiang,
2024, 14(12):5435-5450. DOI:10.1016/j.apsb.2024.08.007
Abstract
Dual alarmin-receptor-specific targeting peptide systems for treatment of sepsis
Seok-Jun Mun, Euni Cho, Woo Jin Gil, Seong Jae Kim, Hyo Keun Kim, Yu Seong Ham, Chul-Su Yang,
2024, 14(12):5451-5463. DOI:10.1016/j.apsb.2024.08.015
Abstract
Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator
Xue Xia, Ya Wei, Qianqian Huang, Yang Zhou, Xiaorong Wang, Yulong Shi, Xiaotong Yang, Wenqin Yang, Yiwei Zhang, Ting Lei, Yuan Huang, Hanmei Li, Meng Qin, Huile Gao,
2024, 14(12):5464-5478. DOI:10.1016/j.apsb.2024.05.017
Abstract
Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM-CSF
Heung Jin Jeon, Daejin Lim, EunA So, Solbi Kim, Jae-Ho Jeong, Miryoung Song, Hyo-Jin Lee,
2024, 14(12):5479-5492. DOI:10.1016/j.apsb.2024.07.011
Abstract
Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapy
Jun Chen, Taige Zhao, Wenbin Hong, Hongsheng Li, Mingtao Ao, Yijing Zhong, Xiaoya Chen, Yingkun Qiu, Xiumin Wang, Zhen Wu, Tianwei Lin, Baicun Li, Xueqin Chen, Meijuan Fang,
2024, 14(12):5493-5504. DOI:10.1016/j.apsb.2024.07.012
Abstract
Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE-/- mice
Meijie Chen, Peter J. Little, Sudong Kong, Maciej Banach, Jianping Weng, Suowen Xu,
2024, 14(12):5505-5508. DOI:10.1016/j.apsb.2024.10.008
Abstract
New functions of oxylipins released by pyroptotic cells
Hui Xu, Hong-Li Tan, Hua-Jun Wang, Xiao-Fei Zheng, Yan-Ping Wu, Rong-Rong He,
2024, 14(12):5509-5511. DOI:10.1016/j.apsb.2024.10.007
Abstract
Sunlenca® (Lenacapavir): A first-in-class, long-acting HIV-1 capsid inhibitor for treating highly multidrug-resistant HIV-1 infection
Chunhua Ma, Junbiao Chang, Bin Yu,
2024, 14(12):5512-5514. DOI:10.1016/j.apsb.2024.08.009
Abstract
Cell carriers change the in vivo fate of nanoparticles
Xiaotong Li, Jianhua He, Wei He,
2024, 14(12):5515-5517. DOI:10.1016/j.apsb.2024.08.011
Abstract
Heterologous biosynthesis of saponin adjuvants from Quillaja saponaria: A symbolic achievement in metabolic engineering
Weiqiang Chen, Zhichao Xu, Wei Sun,
2024, 14(12):5518-5520. DOI:10.1016/j.apsb.2024.09.013
Abstract